Hantz Financial Services Inc. Increases Stock Position in Smith & Nephew plc (NYSE:SNN)

Hantz Financial Services Inc. grew its stake in Smith & Nephew plc (NYSE:SNN) by 14.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,437 shares of the medical equipment provider’s stock after buying an additional 8,917 shares during the period. Hantz Financial Services Inc.’s holdings in Smith & Nephew were worth $2,225,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in SNN. Mather Group LLC. increased its stake in Smith & Nephew by 9,735.3% in the second quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock valued at $42,000 after acquiring an additional 1,655 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in shares of Smith & Nephew by 1,894.3% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 1,648 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of Smith & Nephew by 92.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after purchasing an additional 1,179 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Smith & Nephew by 160.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock valued at $70,000 after buying an additional 1,389 shares in the last quarter. Finally, Opal Wealth Advisors LLC purchased a new position in shares of Smith & Nephew during the 2nd quarter valued at about $101,000. Institutional investors own 25.64% of the company’s stock.

Smith & Nephew Stock Performance

NYSE SNN opened at $25.78 on Friday. Smith & Nephew plc has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The stock has a 50 day simple moving average of $27.58 and a two-hundred day simple moving average of $27.89. The company has a current ratio of 2.51, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63.

Wall Street Analysts Forecast Growth

Several research firms recently commented on SNN. Berenberg Bank lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Finally, StockNews.com lowered shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.